🔎 Trials Near Me

Home › Overweight › Texas › San Antonio

Pag-aaral pangklinika para sa Overweight sa San Antonio, TX

34 pag-aaral para sa Overweight ang naghahanap ng mga kalahok sa mga site sa loob at paligid ng San Antonio (sa loob ng humigit-kumulang 30 milya). Buksan ang pag-aaral upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes

Nagre-recruitPhase 3
  • Pinnacle Clinical Research - South San Antonio, San Antonio
  • IMA Clinical Research - San Antonio, San Antonio
  • Consano Clinical Research, Shavano Park · 12 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 9, 2026 · NCT07351045

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes

Nagre-recruitPhase 3
  • Pinnacle Clinical Research - San Antonio, San Antonio
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 9, 2026 · NCT07351058

Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)

Nagre-recruitPhase 3
  • American Research Corporation, San Antonio
  • Gastroenterology Clinic of San Antonio PA, San Antonio
  • VIP Trials, San Antonio
Edad 18 hanggang 99 · Lahat ng kasarian · Na-update Nob 6, 2026 · NCT07575399

A Study to Learn About Study Medicine Called Berobenatide in Adults With Knee Pain and Overweight or Obesity (VESPER-OA 1)

Nagre-recruitPhase 3
  • Consano Clinical Research, LLC, Shavano Park · 12 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 5, 2026 · NCT07919678

A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity

Nagre-recruitPhase 3
  • IMA Clinical Research San Antonio, San Antonio
  • VIP Trials, San Antonio
  • Consano Clinical Research, LLC, Shavano Park · 12 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 5, 2026 · NCT07794579

A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity

Nagre-recruitPhase 3
  • VIP Trials, San Antonio
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 5, 2026 · NCT07595549

A Study of EloraTZP in Adult Participants With Obesity or Overweight and Type 2 Diabetes

Nagre-recruitPhase 3
  • IMA Clinical Research San Antonio, San Antonio
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 4, 2026 · NCT07881458

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

Nagre-recruitPhase 3
  • IMA Clinical Research San Antonio, San Antonio
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 4, 2026 · NCT07282600

A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin

Nagre-recruitPhase 3
  • IMA Clinical Research San Antonio, San Antonio
  • Endeavor Clinical Trials, San Antonio
  • Consano Clinical Research, LLC, Shavano Park · 12 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 4, 2026 · NCT07392190

Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight

Nagre-recruitPhase 3
  • VIP Trials, San Antonio
  • Endeavor Clinical Trials, San Antonio
  • Consano Clinical Research, LLC, Shavano Park · 12 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 4, 2026 · NCT07353931

Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight

Nagre-recruitPhase 3
  • Gastroenterology Research of San Antonio, San Antonio
  • Southern Star Research Institute, San Antonio
Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Nob 4, 2026 · NCT06937099

A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight

Nagre-recruitPhase 3
  • Sleep Therapy Research Center, San Antonio
  • Consano Clinical Research, LLC, Shavano Park · 12 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 4, 2026 · NCT07369011

Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study

Nagre-recruitPhase 3
  • Gastroenterology Research of San Antonio, San Antonio
  • Southern Star Research Institute, San Antonio
Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Nob 4, 2026 · NCT06937086

A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide

Nagre-recruitPhase 2
  • Consano Clinical Research, LLC, Shavano Park · 12 mi ang layo
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Nob 4, 2026 · NCT06897475

A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus

Nagre-recruitPhase 3
  • Research Site, San Antonio
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 30, 2026 · NCT07784725

A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight

Nagre-recruitPhase 3
  • Research Site, San Antonio
  • Research Site, San Antonio
  • Research Site, San Antonio
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 28, 2026 · NCT07784270

Study to Assess the Effect and Safety of ALV-100 on Maintenance of Weight Loss

Nagre-recruitPhase 2
  • DM Clinical Research - Dominion Family Healthcare, San Antonio
  • Tekton Research, San Antonio
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Okt 26, 2026 · NCT07837973

A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)

Nagre-recruitPhase 3Malugod na tinatanggap ang malusog na boluntaryo
  • ACCOMPLISH-2 Research Site, San Antonio
  • ACCOMPLISH-2 Research Site, San Antonio
Edad 18 hanggang 79 · Lahat ng kasarian · Na-update Okt 20, 2026 · NCT07654374

A Study of LY4174794 in Participants With Obesity or Overweight Who Are Otherwise Healthy

Nagre-recruitPhase 1Malugod na tinatanggap ang malusog na boluntaryo
  • ICON Early Phase Services, LLC, San Antonio
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Okt 15, 2026 · NCT07654972

A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight

Nagre-recruitPhase 2
  • Endeavor Clinical Trials, San Antonio
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Okt 8, 2026 · NCT07589608

A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight

Nagre-recruitPhase 2
  • Endeavor Clinical Trials, San Antonio
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Okt 7, 2026 · NCT06143956

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)

Nagre-recruitPhase 3
  • Clinical Trials of Texas, San Antonio
Edad 18 hanggang 99 · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT07684235

A Study to Evaluate the Impact of Renal Impairment on the Pharmacokinetics (PK) of Ribupatide

Nagre-recruitPhase 1Malugod na tinatanggap ang malusog na boluntaryo
  • Kailera Clinical Site, San Antonio
Edad 18 hanggang 85 · Lahat ng kasarian · Na-update Okt 1, 2026 · NCT07793929

A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight

Nagre-recruitPhase 3
  • DM Clinical, San Antonio
  • The Texas Liver Institute, San Antonio
  • Pinnacle Clinical Research, San Antonio
  • at 1 pa
Edad 8 hanggang 18 · Lahat ng kasarian · Na-update Set 30, 2026 · NCT07253285

A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide

Nagre-recruitPhase 3
  • Sleep Therapy Research Center, San Antonio
Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT07668414

A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes

Nagre-recruitPhase 3
  • IMA Clinical Research San Antonio, San Antonio
Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07321886

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

Nagre-recruitPhase 3
  • AURORA-2 Clinical Site, San Antonio
  • AURORA-2 Clinical Site, San Antonio
Edad 18 pataas · Lahat ng kasarian · Na-update Set 16, 2026 · NCT07743450

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities

Nagre-recruitPhase 3
  • AURORA-1 Clinical Site, San Antonio
  • AURORA-1 Clinical Site, San Antonio
Edad 18 pataas · Lahat ng kasarian · Na-update Set 16, 2026 · NCT07743463

A First-in-human Research Study on How NNC0721-8060 Works in People Living With Overweight or Obesity

Nagre-recruitPhase 1Malugod na tinatanggap ang malusog na boluntaryo
  • ICON, San Antonio
Edad 18 hanggang 55 · Lahat ng kasarian · Na-update Set 4, 2026 · NCT07767175

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight

Nagre-recruitPhase 1Malugod na tinatanggap ang malusog na boluntaryo
  • ICON Early Phase Services, San Antonio
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Ago 20, 2026 · NCT07738614

Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)

Nagre-recruitPhase 3
  • ACCOMPLISH-1 Research Site, San Antonio
Edad 18 hanggang 79 · Lahat ng kasarian · Na-update Ago 10, 2026 · NCT07654361

Pag-aaral para sa Overweight sa ibang lungsod

Iba pang pag-aaral sa San Antonio

Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.